microRNA information: hsa-miR-183-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-183-5p | miRbase |
| Accession: | MIMAT0000261 | miRbase |
| Precursor name: | hsa-mir-183 | miRbase |
| Precursor accession: | MI0000273 | miRbase |
| Symbol: | MIR183 | HGNC |
| RefSeq ID: | NR_029615 | GenBank |
| Sequence: | UAUGGCACUGGUAGAAUUCACU |
Reported expression in cancers: hsa-miR-183-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-183-5p | bladder cancer | upregulation | "MicroRNA expression signatures of bladder cancer r ......" | 21464941 | RNA-Seq; qPCR |
| hsa-miR-183-5p | breast cancer | upregulation | "MiR-182 is a member of the miR-183 cluster located ......" | 23333633 | |
| hsa-miR-183-5p | breast cancer | upregulation | "Between them hsa-miR-183 was the most significativ ......" | 25277099 | |
| hsa-miR-183-5p | cervical and endocervical cancer | downregulation | "miR-183 was found to inhibit or promote the invasi ......" | 26873866 | qPCR |
| hsa-miR-183-5p | colon cancer | upregulation | "To present proof-of-principle application for empl ......" | 23741026 | qPCR; Microarray |
| hsa-miR-183-5p | colorectal cancer | upregulation | "Overexpression of microRNA 183 in human colorectal ......" | 24150523 | qPCR |
| hsa-miR-183-5p | esophageal cancer | upregulation | "MicroRNA 183 promotes proliferation and invasion i ......" | 25211657 | Microarray |
| hsa-miR-183-5p | gastric cancer | downregulation | "Real-time PCR was used to detect the miR-183 expre ......" | 22851079 | qPCR |
| hsa-miR-183-5p | gastric cancer | downregulation | "MicroRNA 183 inhibits gastric cancer proliferation ......" | 25295122 | qPCR |
| hsa-miR-183-5p | gastric cancer | deregulation | "miR-183 a member of an evolutionarily conserved mi ......" | 25337200 | |
| hsa-miR-183-5p | gastric cancer | upregulation | "Aberrant expression of miR-183 has been frequently ......" | 25356105 | |
| hsa-miR-183-5p | gastric cancer | upregulation | "MicroRNA-183 miR-183 has recently been identified ......" | 26961483 | |
| hsa-miR-183-5p | liver cancer | upregulation | "The expression profiles of miR-183 were compared b ......" | 20602797 | qPCR |
| hsa-miR-183-5p | liver cancer | upregulation | "Expression and significance of microRNA 183 in hep ......" | 24222732 | |
| hsa-miR-183-5p | liver cancer | upregulation | "Compared with the matched NT tissues 9 miRNAs were ......" | 24273923 | |
| hsa-miR-183-5p | liver cancer | upregulation | "Both miR-21 and miR-183 are upregulated in hepatoc ......" | 26400524 | qPCR |
| hsa-miR-183-5p | liver cancer | upregulation | "MiR-183 acts as an oncomiR and is usually upregula ......" | 27249600 | |
| hsa-miR-183-5p | lung cancer | upregulation | "Some representative cases from each group were pro ......" | 26170125 | Microarray; Reverse transcription PCR; qPCR |
| hsa-miR-183-5p | lung squamous cell cancer | deregulation | "Diagnostic Value of Serum miR 182 miR 183 miR 210 ......" | 27093275 | Reverse transcription PCR |
| hsa-miR-183-5p | ovarian cancer | upregulation | "To identify the micro-ribonucleic acids miRNAs exp ......" | 24816756 | qPCR |
| hsa-miR-183-5p | prostate cancer | downregulation | "We investigated the expression profiles of 6 micro ......" | 20873592 | Microarray; in situ hybridization |
| hsa-miR-183-5p | thyroid cancer | upregulation | "miR 183 regulates biological behavior in papillary ......" | 26063221 | qPCR |
Reported cancer pathway affected by hsa-miR-183-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-183-5p | acute myeloid leukemia | Apoptosis pathway; cell cycle pathway | "MicroRNA 183 promotes cell proliferation via regul ......" | 27738758 | Luciferase |
| hsa-miR-183-5p | bladder cancer | Apoptosis pathway | "Synthetic miRNA mowers targeting miR 183 96 182 cl ......" | 23284967 | Luciferase; Flow cytometry; MTT assay |
| hsa-miR-183-5p | breast cancer | Apoptosis pathway | "Dysregulated miR 183 inhibits migration in breast ......" | 20858276 | |
| hsa-miR-183-5p | breast cancer | cell cycle pathway | "The miRNA level was detected by LNA-based northern ......" | 25394902 | Luciferase; Flow cytometry; Colony formation; MTT assay; Wound Healing Assay; Western blot |
| hsa-miR-183-5p | breast cancer | Wnt signaling pathway; Apoptosis pathway; Notch signaling pathway | "The miRNAs and their clusters such as the miR-200 ......" | 26712794 | |
| hsa-miR-183-5p | breast cancer | Apoptosis pathway | "We found that the miR-183-5p expression level was ......" | 27476679 | |
| hsa-miR-183-5p | colon cancer | Apoptosis pathway | "MiR 183 functions as an oncogene by targeting ABCA ......" | 26935154 | |
| hsa-miR-183-5p | colorectal cancer | Apoptosis pathway | "miR 183 regulates autophagy and apoptosis in color ......" | 26717041 | |
| hsa-miR-183-5p | esophageal cancer | Apoptosis pathway | "In the present study we explored the oncogenic rol ......" | 25518924 | Western blot; Luciferase |
| hsa-miR-183-5p | gastric cancer | cell cycle pathway | "miR 183 inhibits invasion of gastric cancer by tar ......" | 25337200 | |
| hsa-miR-183-5p | gastric cancer | Apoptosis pathway | "MicroRNA 183 inhibits apoptosis and promotes proli ......" | 25356105 | |
| hsa-miR-183-5p | gastric cancer | Apoptosis pathway | "MicroRNA 183 Functions As an Oncogene by Regulatin ......" | 26961483 | Colony formation |
| hsa-miR-183-5p | liver cancer | Apoptosis pathway | "miR 183 inhibits TGF beta1 induced apoptosis by do ......" | 20602797 | Luciferase |
| hsa-miR-183-5p | liver cancer | Apoptosis pathway | "MiR 21 and miR 183 can simultaneously target SOCS6 ......" | 26400524 | Western blot; Luciferase |
| hsa-miR-183-5p | lung cancer | cell cycle pathway | "TFAP2C promotes lung tumorigenesis and aggressiven ......" | 27593936 | |
| hsa-miR-183-5p | pancreatic cancer | Apoptosis pathway | "miR 183 induces cell proliferation migration and i ......" | 25776494 | |
| hsa-miR-183-5p | thyroid cancer | Apoptosis pathway | "A miR-microarray study was conducted to identify m ......" | 24631480 | |
| hsa-miR-183-5p | thyroid cancer | Apoptosis pathway | "miR 183 regulates biological behavior in papillary ......" | 26063221 | Flow cytometry; Colony formation; Luciferase; Western blot |
Reported cancer prognosis affected by hsa-miR-183-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-183-5p | acute myeloid leukemia | malignant trasformation; poor survival | "MicroRNA 183 promotes cell proliferation via regul ......" | 27738758 | Luciferase |
| hsa-miR-183-5p | breast cancer | metastasis | "Dysregulated miR 183 inhibits migration in breast ......" | 20858276 | |
| hsa-miR-183-5p | breast cancer | worse prognosis | "Between them hsa-miR-183 was the most significativ ......" | 25277099 | |
| hsa-miR-183-5p | breast cancer | poor survival | "The miRNA level was detected by LNA-based northern ......" | 25394902 | Luciferase; Flow cytometry; Colony formation; MTT assay; Wound Healing Assay; Western blot |
| hsa-miR-183-5p | breast cancer | staging | "Dynamic analysis of MTUS1 expression levels and it ......" | 27155522 | |
| hsa-miR-183-5p | cervical and endocervical cancer | metastasis | "MicroRNA 183 functions as the tumor suppressor via ......" | 26873866 | Luciferase |
| hsa-miR-183-5p | colon cancer | staging | "To present proof-of-principle application for empl ......" | 23741026 | |
| hsa-miR-183-5p | colorectal cancer | poor survival; staging; metastasis; worse prognosis | "Overexpression of microRNA 183 in human colorectal ......" | 24150523 | |
| hsa-miR-183-5p | colorectal cancer | worse prognosis; recurrence; staging; metastasis; poor survival | "Plasma miR 183 predicts recurrence and prognosis i ......" | 25629978 | |
| hsa-miR-183-5p | colorectal cancer | progression | "miR 183 regulates autophagy and apoptosis in color ......" | 26717041 | |
| hsa-miR-183-5p | colorectal cancer | worse prognosis | "Screening miRNAs for early diagnosis of colorectal ......" | 27022275 | |
| hsa-miR-183-5p | endometrial cancer | malignant trasformation | "Expression profiling of normal and malignant endom ......" | 20028871 | |
| hsa-miR-183-5p | esophageal cancer | staging; metastasis | "MicroRNA 183 promotes proliferation and invasion i ......" | 25211657 | Western blot; Luciferase |
| hsa-miR-183-5p | gastric cancer | staging; metastasis; differentiation; worse prognosis | "Expression of microRNA 183 in stage II gastric ca ......" | 22851079 | |
| hsa-miR-183-5p | gastric cancer | staging; metastasis | "miR 183 inhibits invasion of gastric cancer by tar ......" | 25337200 | |
| hsa-miR-183-5p | gastric cancer | staging; metastasis; cell migration; progression | "MicroRNA 183 inhibits apoptosis and promotes proli ......" | 25356105 | |
| hsa-miR-183-5p | gastric cancer | metastasis | "MicroRNA 183 Functions As an Oncogene by Regulatin ......" | 26961483 | Colony formation |
| hsa-miR-183-5p | gastric cancer | poor survival; staging; metastasis; differentiation | "Then we further investigated these GC specific miR ......" | 27173517 | |
| hsa-miR-183-5p | liver cancer | progression; staging; poor survival | "Expression and significance of microRNA 183 in hep ......" | 24222732 | |
| hsa-miR-183-5p | liver cancer | drug resistance | "MiR 183 modulates multi drug resistance in hepatoc ......" | 27249600 | Western blot; MTT assay |
| hsa-miR-183-5p | lung cancer | metastasis | "MicroRNA 183 regulates Ezrin expression in lung ca ......" | 18840437 | |
| hsa-miR-183-5p | lung cancer | poor survival; worse prognosis | "Overexpression of members of the microRNA 183 fami ......" | 21920043 | |
| hsa-miR-183-5p | lung cancer | motility | "MicroRNA 183 promotes migration and invasion of CD ......" | 26951513 | Luciferase |
| hsa-miR-183-5p | lung cancer | tumorigenesis | "TFAP2C promotes lung tumorigenesis and aggressiven ......" | 27593936 | |
| hsa-miR-183-5p | lung squamous cell cancer | staging | "There was statistical difference in the serum leve ......" | 22009180 | |
| hsa-miR-183-5p | lung squamous cell cancer | progression; staging | "With the use of next-generation deep sequencing te ......" | 25813410 | |
| hsa-miR-183-5p | lung squamous cell cancer | staging | "Diagnostic Value of Serum miR 182 miR 183 miR 210 ......" | 27093275 | |
| hsa-miR-183-5p | ovarian cancer | metastasis | "the differential expression of ezrin in two paired ......" | 21176563 | Western blot |
| hsa-miR-183-5p | pancreatic cancer | cell migration | "miR 183 induces cell proliferation migration and i ......" | 25776494 | |
| hsa-miR-183-5p | pancreatic cancer | metastasis; motility | "MicroRNA 183 5p promotes the proliferation invasio ......" | 26870180 | Western blot |
| hsa-miR-183-5p | prostate cancer | poor survival; motility | "microRNA 183 is an oncogene targeting Dkk 3 and SM ......" | 23538390 | Wound Healing Assay |
| hsa-miR-183-5p | prostate cancer | progression | "miR 183 in prostate cancer cells positively regula ......" | 25556023 | Western blot |
| hsa-miR-183-5p | sarcoma | metastasis; recurrence | "Down regulation of miR 183 promotes migration and ......" | 22525461 | Luciferase; RNAi |
| hsa-miR-183-5p | sarcoma | metastasis; motility; cell migration | "miR 183 inhibits the metastasis of osteosarcoma vi ......" | 22922800 | |
| hsa-miR-183-5p | sarcoma | worse prognosis; metastasis; recurrence; drug resistance; progression | "MicroRNA-183 miR-183 has been demonstrated to be a ......" | 24352761 |
Reported gene related to hsa-miR-183-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-183-5p | breast cancer | EZR | "Specifically the VIL2-coding protein Ezrin was con ......" | 20858276 |
| hsa-miR-183-5p | gastric cancer | EZR | "Expression of microRNA 183 in stage II gastric ca ......" | 22851079 |
| hsa-miR-183-5p | gastric cancer | EZR | "miR 183 inhibits invasion of gastric cancer by tar ......" | 25337200 |
| hsa-miR-183-5p | lung cancer | EZR | "MicroRNA 183 regulates Ezrin expression in lung ca ......" | 18840437 |
| hsa-miR-183-5p | ovarian cancer | EZR | "2 By a functional screen using miRNA microarray co ......" | 21176563 |
| hsa-miR-183-5p | sarcoma | EZR | "MicroRNA-183 miR-183 has been demonstrated to be a ......" | 24352761 |
| hsa-miR-183-5p | sarcoma | EZR | "Down regulation of miR 183 promotes migration and ......" | 22525461 |
| hsa-miR-183-5p | sarcoma | EZR | "miR 183 inhibits the metastasis of osteosarcoma vi ......" | 22922800 |
| hsa-miR-183-5p | breast cancer | PDCD4 | "Moreover PDCD4 was predicted as a putative target ......" | 27476679 |
| hsa-miR-183-5p | esophageal cancer | PDCD4 | "Western blot analysis showed that the expression o ......" | 25518924 |
| hsa-miR-183-5p | esophageal cancer | PDCD4 | "The expression of miR-183 and programmed cell deat ......" | 25211657 |
| hsa-miR-183-5p | gastric cancer | PDCD4 | "MicroRNA 183 inhibits apoptosis and promotes proli ......" | 25356105 |
| hsa-miR-183-5p | gastric cancer | PDCD4 | "MicroRNA 183 Functions As an Oncogene by Regulatin ......" | 26961483 |
| hsa-miR-183-5p | liver cancer | PDCD4 | "miR 183 inhibits TGF beta1 induced apoptosis by do ......" | 20602797 |
| hsa-miR-183-5p | pancreatic cancer | PDCD4 | "miR 183 induces cell proliferation migration and i ......" | 25776494 |
| hsa-miR-183-5p | thyroid cancer | PDCD4 | "The aim of the present study was to examine the ex ......" | 26063221 |
| hsa-miR-183-5p | liver cancer | SOCS6 | "Both SOCS6 overexpression and miR-183 knockdown si ......" | 27249600 |
| hsa-miR-183-5p | liver cancer | SOCS6 | "MiR 21 and miR 183 can simultaneously target SOCS6 ......" | 26400524 |
| hsa-miR-183-5p | pancreatic cancer | SOCS6 | "Western blot analysis was used to confirm SOCS-6 a ......" | 26870180 |
| hsa-miR-183-5p | liver cancer | FOXO1 | "Knockdown of CTNNB1 also showed concordant down-re ......" | 25813403 |
| hsa-miR-183-5p | lung squamous cell cancer | FOXO1 | "MiR 183 promotes growth of non small cell lung can ......" | 25983004 |
| hsa-miR-183-5p | colon cancer | ABCA1 | "MiR 183 functions as an oncogene by targeting ABCA ......" | 26935154 |
| hsa-miR-183-5p | breast cancer | AMACR | "IsomiR expression is also dependent on the patient ......" | 26400174 |
| hsa-miR-183-5p | pancreatic cancer | BCL2 | "Here we have reported the reduction in pancreatic ......" | 25776494 |
| hsa-miR-183-5p | pancreatic cancer | CDH1 | "miR-183 inhibition was shown to increase E-cadheri ......" | 25776494 |
| hsa-miR-183-5p | pancreatic cancer | CDH2 | "miR-183 inhibition was shown to increase E-cadheri ......" | 25776494 |
| hsa-miR-183-5p | colorectal cancer | CEACAM5 | "The value of the area under the receiver operating ......" | 25629978 |
| hsa-miR-183-5p | lung cancer | CEP290 | "In the present study we explored the regulation of ......" | 26951513 |
| hsa-miR-183-5p | liver cancer | CTNNB1 | "Knockdown of CTNNB1 also showed concordant down-re ......" | 25813403 |
| hsa-miR-183-5p | prostate cancer | DKK3 | "microRNA 183 is an oncogene targeting Dkk 3 and SM ......" | 23538390 |
| hsa-miR-183-5p | lung cancer | EGFR | "Moreover expression level of miR-183 was significa ......" | 26170125 |
| hsa-miR-183-5p | breast cancer | ESR1 | "We demonstrate that miR-183 is dysregulated in bre ......" | 20858276 |
| hsa-miR-183-5p | prostate cancer | F2 | "Additionally miR-183 expression was correlated wit ......" | 23538390 |
| hsa-miR-183-5p | retinoblastoma | LRP6 | "MicroRNA 183 suppresses retinoblastoma cell growth ......" | 24289859 |
| hsa-miR-183-5p | thyroid cancer | MAP1LC3B | "Knock down of miR-183 expression in the TT cell li ......" | 21622722 |
| hsa-miR-183-5p | cervical and endocervical cancer | MMP9 | "MicroRNA 183 functions as the tumor suppressor via ......" | 26873866 |
| hsa-miR-183-5p | breast cancer | MTUS1 | "Also among MTUS1 targeting miRNAs miR-183-5p was i ......" | 27155522 |
| hsa-miR-183-5p | liver cancer | NTS | "MiR-183 expression was measured in normal controls ......" | 24222732 |
| hsa-miR-183-5p | prostate cancer | PCA3 | "Urinary miR 183 and miR 205 do not surpass PCA3 in ......" | 25720086 |
| hsa-miR-183-5p | acute myeloid leukemia | PDCD6 | "Bioinformatics prediction and luciferase reporter ......" | 27738758 |
| hsa-miR-183-5p | lung cancer | PTPN4 | "MicroRNA 183 promotes migration and invasion of CD ......" | 26951513 |
| hsa-miR-183-5p | breast cancer | RAB21 | "MiR-183 targeted the RAB21 mRNA directly in breast ......" | 25394902 |
| hsa-miR-183-5p | prostate cancer | SMAD4 | "microRNA 183 is an oncogene targeting Dkk 3 and SM ......" | 23538390 |
| hsa-miR-183-5p | lung cancer | TFAP2C | "TFAP2C promotes lung tumorigenesis and aggressiven ......" | 27593936 |
| hsa-miR-183-5p | thyroid cancer | TPCN1 | "MTT colony formation wound-healing and Transwell i ......" | 26063221 |
| hsa-miR-183-5p | prostate cancer | TWIST1 | "Compared with the primary tumor the metastatic cel ......" | 25409297 |
| hsa-miR-183-5p | colorectal cancer | UVRAG | "miR 183 regulates autophagy and apoptosis in color ......" | 26717041 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-183-5p | AKAP12 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.329; TCGA BRCA -0.537; TCGA COAD -0.511; TCGA ESCA -0.479; TCGA HNSC -0.218; TCGA LIHC -0.111; TCGA LUAD -0.268; TCGA LUSC -0.549; TCGA PAAD -0.367; TCGA PRAD -0.284; TCGA SARC -0.147; TCGA THCA -0.149; TCGA STAD -0.573; TCGA UCEC -0.34 |
hsa-miR-183-5p | CR1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.655; TCGA BRCA -0.408; TCGA CESC -0.283; TCGA COAD -0.525; TCGA ESCA -0.63; TCGA HNSC -0.407; TCGA KIRP -0.226; TCGA LGG -0.079; TCGA LIHC -0.118; TCGA LUAD -0.373; TCGA LUSC -0.751; TCGA OV -0.216; TCGA PAAD -0.741; TCGA PRAD -0.237; TCGA SARC -0.263; TCGA THCA -0.61; TCGA STAD -0.272 |
hsa-miR-183-5p | DOCK1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.093; TCGA BRCA -0.146; TCGA CESC -0.084; TCGA COAD -0.086; TCGA ESCA -0.08; TCGA HNSC -0.08; TCGA KIRP -0.057; TCGA LUSC -0.11; TCGA PRAD -0.155; TCGA STAD -0.091; TCGA UCEC -0.136 |
hsa-miR-183-5p | EGR1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.413; TCGA BRCA -0.572; TCGA CESC -0.132; TCGA COAD -0.183; TCGA ESCA -0.161; TCGA HNSC -0.136; TCGA KIRP -0.346; TCGA LGG -0.079; TCGA LIHC -0.122; TCGA LUAD -0.412; TCGA LUSC -0.234; TCGA OV -0.15; TCGA PAAD -0.216; TCGA PRAD -0.401; TCGA STAD -0.265; TCGA UCEC -0.305 |
hsa-miR-183-5p | FAM110B | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.414; TCGA CESC -0.144; TCGA COAD -0.529; TCGA ESCA -0.245; TCGA HNSC -0.222; TCGA LUAD -0.214; TCGA LUSC -0.124; TCGA THCA -0.19; TCGA STAD -0.349; TCGA UCEC -0.259 |
hsa-miR-183-5p | FOXO1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.127; TCGA BRCA -0.397; TCGA CESC -0.16; TCGA COAD -0.257; TCGA ESCA -0.117; TCGA HNSC -0.193; TCGA KIRP -0.092; TCGA LIHC -0.17; TCGA LUAD -0.319; TCGA LUSC -0.179; TCGA OV -0.141; TCGA PAAD -0.196; TCGA PRAD -0.272; TCGA SARC -0.085; TCGA STAD -0.09; TCGA UCEC -0.245 |
hsa-miR-183-5p | GAS1 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.694; TCGA BRCA -0.419; TCGA CESC -0.282; TCGA COAD -0.76; TCGA HNSC -0.225; TCGA KIRP -0.404; TCGA LUAD -0.286; TCGA LUSC -0.326; TCGA OV -0.199; TCGA PAAD -0.576; TCGA PRAD -0.598; TCGA THCA -0.294; TCGA STAD -0.58; TCGA UCEC -0.569 |
hsa-miR-183-5p | GATA6 | 9 cancers: BLCA; BRCA; ESCA; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.564; TCGA BRCA -0.154; TCGA ESCA -0.519; TCGA LUAD -0.448; TCGA LUSC -0.583; TCGA OV -0.27; TCGA PRAD -0.11; TCGA THCA -0.147; TCGA UCEC -0.544 |
hsa-miR-183-5p | GLUL | 13 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.117; TCGA CESC -0.161; TCGA COAD -0.101; TCGA HNSC -0.129; TCGA KIRP -0.083; TCGA LIHC -0.291; TCGA LUAD -0.093; TCGA LUSC -0.121; TCGA OV -0.066; TCGA PAAD -0.142; TCGA PRAD -0.16; TCGA SARC -0.068; TCGA STAD -0.125 |
hsa-miR-183-5p | HLA-A | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.19; TCGA CESC -0.188; TCGA ESCA -0.137; TCGA HNSC -0.13; TCGA KIRC -0.106; TCGA LUAD -0.117; TCGA LUSC -0.275; TCGA PRAD -0.176; TCGA SARC -0.084; TCGA THCA -0.21 |
hsa-miR-183-5p | ITGA5 | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.527; TCGA BRCA -0.065; TCGA COAD -0.408; TCGA ESCA -0.165; TCGA KIRC -0.169; TCGA LGG -0.08; TCGA LUAD -0.259; TCGA LUSC -0.265; TCGA PAAD -0.312; TCGA PRAD -0.444; TCGA SARC -0.174; TCGA STAD -0.263; TCGA UCEC -0.122 |
hsa-miR-183-5p | ITGA8 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.4; TCGA BRCA -0.278; TCGA CESC -0.407; TCGA ESCA -0.822; TCGA HNSC -0.289; TCGA KIRC -0.133; TCGA KIRP -0.51; TCGA LUAD -0.55; TCGA LUSC -0.971; TCGA OV -0.158; TCGA PAAD -0.509; TCGA PRAD -0.771; TCGA SARC -0.286; TCGA STAD -0.559; TCGA UCEC -0.531 |
hsa-miR-183-5p | ITGB1 | 11 cancers: BLCA; BRCA; COAD; KIRC; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.113; TCGA BRCA -0.096; TCGA COAD -0.056; TCGA KIRC -0.053; TCGA LGG -0.052; TCGA LUSC -0.129; TCGA PAAD -0.09; TCGA PRAD -0.151; TCGA SARC -0.106; TCGA STAD -0.132; TCGA UCEC -0.063 |
hsa-miR-183-5p | ITPKB | 12 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; LUAD; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.201; TCGA BRCA -0.118; TCGA CESC -0.08; TCGA COAD -0.143; TCGA KIRP -0.177; TCGA LGG -0.104; TCGA LUAD -0.069; TCGA OV -0.068; TCGA PAAD -0.185; TCGA PRAD -0.071; TCGA STAD -0.424; TCGA UCEC -0.137 |
hsa-miR-183-5p | KIAA0430 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.051; TCGA BRCA -0.06; TCGA CESC -0.082; TCGA COAD -0.06; TCGA ESCA -0.119; TCGA HNSC -0.066; TCGA LUAD -0.101; TCGA LUSC -0.101; TCGA PRAD -0.1; TCGA THCA -0.09; TCGA STAD -0.176; TCGA UCEC -0.111 |
hsa-miR-183-5p | MYCBP2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.096; TCGA BRCA -0.231; TCGA CESC -0.179; TCGA COAD -0.082; TCGA HNSC -0.136; TCGA LUAD -0.13; TCGA LUSC -0.082; TCGA OV -0.085; TCGA PAAD -0.095; TCGA PRAD -0.17; TCGA THCA -0.111; TCGA STAD -0.076; TCGA UCEC -0.152 |
hsa-miR-183-5p | NHSL2 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.343; TCGA BRCA -0.226; TCGA COAD -0.518; TCGA ESCA -0.451; TCGA HNSC -0.176; TCGA KIRC -0.1; TCGA KIRP -0.354; TCGA LUAD -0.23; TCGA LUSC -0.357; TCGA PAAD -0.299; TCGA PRAD -0.563; TCGA SARC -0.091; TCGA STAD -0.498; TCGA UCEC -0.115 |
hsa-miR-183-5p | NOTCH2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.187; TCGA BRCA -0.071; TCGA CESC -0.096; TCGA COAD -0.162; TCGA ESCA -0.116; TCGA HNSC -0.143; TCGA LUSC -0.114; TCGA PAAD -0.34; TCGA THCA -0.27; TCGA STAD -0.173; TCGA UCEC -0.091 |
hsa-miR-183-5p | REV3L | 10 cancers: BLCA; BRCA; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.155; TCGA BRCA -0.164; TCGA ESCA -0.103; TCGA KIRC -0.065; TCGA LUAD -0.096; TCGA LUSC -0.078; TCGA PAAD -0.131; TCGA PRAD -0.205; TCGA STAD -0.121; TCGA UCEC -0.105 |
hsa-miR-183-5p | RTN4 | 10 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.052; TCGA BRCA -0.082; TCGA HNSC -0.069; TCGA LIHC -0.094; TCGA LUAD -0.061; TCGA LUSC -0.064; TCGA PRAD -0.109; TCGA THCA -0.083; TCGA STAD -0.147; TCGA UCEC -0.098 |
hsa-miR-183-5p | SH3D19 | 12 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.151; TCGA BRCA -0.344; TCGA CESC -0.066; TCGA HNSC -0.078; TCGA LIHC -0.128; TCGA LUAD -0.162; TCGA LUSC -0.234; TCGA PAAD -0.151; TCGA PRAD -0.103; TCGA SARC -0.134; TCGA STAD -0.166; TCGA UCEC -0.21 |
hsa-miR-183-5p | SLC2A3 | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.356; TCGA BRCA -0.182; TCGA COAD -0.163; TCGA ESCA -0.284; TCGA KIRC -0.24; TCGA KIRP -0.133; TCGA LUAD -0.259; TCGA LUSC -0.293; TCGA PAAD -0.262; TCGA PRAD -0.219; TCGA THCA -0.356; TCGA STAD -0.068; TCGA UCEC -0.147 |
hsa-miR-183-5p | STK33 | 9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.272; TCGA BRCA -0.191; TCGA COAD -0.479; TCGA ESCA -0.444; TCGA LGG -0.086; TCGA LUSC -0.335; TCGA PRAD -0.53; TCGA STAD -0.432; TCGA UCEC -0.122 |
hsa-miR-183-5p | TMEM108 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.485; TCGA BRCA -0.188; TCGA COAD -0.27; TCGA HNSC -0.236; TCGA KIRP -0.383; TCGA LUSC -0.391; TCGA PAAD -0.166; TCGA PRAD -0.66; TCGA STAD -0.391; TCGA UCEC -0.161 |
hsa-miR-183-5p | TRO | 11 cancers: BLCA; BRCA; CESC; COAD; KIRP; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.158; TCGA BRCA -0.293; TCGA CESC -0.149; TCGA COAD -0.367; TCGA KIRP -0.12; TCGA LIHC -0.147; TCGA LUAD -0.104; TCGA PAAD -0.142; TCGA PRAD -0.499; TCGA STAD -0.308; TCGA UCEC -0.272 |
hsa-miR-183-5p | TXNIP | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.163; TCGA BRCA -0.397; TCGA CESC -0.311; TCGA COAD -0.165; TCGA ESCA -0.413; TCGA HNSC -0.291; TCGA LIHC -0.093; TCGA LUAD -0.296; TCGA LUSC -0.477; TCGA PRAD -0.174; TCGA SARC -0.107; TCGA THCA -0.131; TCGA STAD -0.425; TCGA UCEC -0.308 |
hsa-miR-183-5p | JAM3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.395; TCGA BRCA -0.298; TCGA CESC -0.2; TCGA COAD -0.356; TCGA ESCA -0.327; TCGA HNSC -0.149; TCGA KIRC -0.198; TCGA KIRP -0.33; TCGA LUAD -0.188; TCGA LUSC -0.336; TCGA OV -0.094; TCGA PAAD -0.225; TCGA PRAD -0.431; TCGA SARC -0.07; TCGA STAD -0.478; TCGA UCEC -0.381 |
hsa-miR-183-5p | BACH2 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.421; TCGA BRCA -0.382; TCGA COAD -0.396; TCGA HNSC -0.121; TCGA KIRP -0.274; TCGA LUAD -0.189; TCGA OV -0.158; TCGA PAAD -0.344; TCGA PRAD -0.23; TCGA THCA -0.456; TCGA STAD -0.299; TCGA UCEC -0.345 |
hsa-miR-183-5p | TMCC3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.344; TCGA BRCA -0.196; TCGA CESC -0.239; TCGA COAD -0.178; TCGA ESCA -0.122; TCGA HNSC -0.209; TCGA KIRC -0.224; TCGA KIRP -0.099; TCGA LUAD -0.222; TCGA LUSC -0.23; TCGA THCA -0.202; TCGA STAD -0.127; TCGA UCEC -0.152 |
hsa-miR-183-5p | PLEKHM3 | 10 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.056; TCGA BRCA -0.294; TCGA COAD -0.079; TCGA ESCA -0.062; TCGA LIHC -0.081; TCGA LUAD -0.058; TCGA LUSC -0.11; TCGA PRAD -0.092; TCGA STAD -0.195; TCGA UCEC -0.173 |
hsa-miR-183-5p | SLC25A20 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD | MirTarget | TCGA BLCA -0.137; TCGA BRCA -0.146; TCGA CESC -0.108; TCGA ESCA -0.219; TCGA HNSC -0.175; TCGA LGG -0.13; TCGA LIHC -0.154; TCGA LUAD -0.1; TCGA LUSC -0.247; TCGA PRAD -0.128 |
hsa-miR-183-5p | PKD2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.192; TCGA BRCA -0.328; TCGA CESC -0.119; TCGA COAD -0.308; TCGA ESCA -0.128; TCGA HNSC -0.054; TCGA LUAD -0.161; TCGA LUSC -0.139; TCGA OV -0.079; TCGA PAAD -0.214; TCGA PRAD -0.164; TCGA SARC -0.099; TCGA STAD -0.391; TCGA UCEC -0.316 |
hsa-miR-183-5p | RAB8B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.083; TCGA BRCA -0.152; TCGA CESC -0.162; TCGA COAD -0.081; TCGA ESCA -0.228; TCGA HNSC -0.104; TCGA LUAD -0.213; TCGA LUSC -0.343; TCGA OV -0.069; TCGA PAAD -0.201; TCGA PRAD -0.054; TCGA SARC -0.053; TCGA STAD -0.115; TCGA UCEC -0.258 |
hsa-miR-183-5p | ST6GALNAC3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.241; TCGA BRCA -0.382; TCGA CESC -0.193; TCGA COAD -0.15; TCGA ESCA -0.419; TCGA HNSC -0.183; TCGA KIRC -0.169; TCGA KIRP -0.379; TCGA LIHC -0.131; TCGA LUAD -0.13; TCGA LUSC -0.49; TCGA PAAD -0.185; TCGA PRAD -0.279; TCGA STAD -0.263; TCGA UCEC -0.308 |
hsa-miR-183-5p | PAM | 10 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.261; TCGA BRCA -0.226; TCGA ESCA -0.145; TCGA HNSC -0.125; TCGA LGG -0.087; TCGA LUSC -0.211; TCGA PRAD -0.211; TCGA THCA -0.121; TCGA STAD -0.212; TCGA UCEC -0.062 |
hsa-miR-183-5p | SAMD4A | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.415; TCGA BRCA -0.373; TCGA CESC -0.167; TCGA COAD -0.255; TCGA ESCA -0.338; TCGA HNSC -0.161; TCGA LIHC -0.117; TCGA LUAD -0.169; TCGA LUSC -0.465; TCGA PAAD -0.262; TCGA PRAD -0.303; TCGA STAD -0.406; TCGA UCEC -0.327 |
hsa-miR-183-5p | ARHGAP6 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.253; TCGA BRCA -0.352; TCGA CESC -0.154; TCGA COAD -0.248; TCGA ESCA -0.53; TCGA HNSC -0.33; TCGA KIRP -0.126; TCGA LUAD -0.506; TCGA LUSC -0.698; TCGA PAAD -0.238; TCGA SARC -0.125; TCGA STAD -0.411; TCGA UCEC -0.553 |
hsa-miR-183-5p | PCGF5 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.113; TCGA BRCA -0.143; TCGA ESCA -0.162; TCGA HNSC -0.107; TCGA KIRP -0.076; TCGA LUAD -0.127; TCGA LUSC -0.148; TCGA PRAD -0.119; TCGA THCA -0.054; TCGA UCEC -0.071 |
hsa-miR-183-5p | DDX58 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.155; TCGA CESC -0.137; TCGA COAD -0.158; TCGA HNSC -0.096; TCGA KIRC -0.077; TCGA LUAD -0.082; TCGA LUSC -0.145; TCGA PAAD -0.11; TCGA SARC -0.069; TCGA THCA -0.104; TCGA STAD -0.06 |
hsa-miR-183-5p | IRS1 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.082; TCGA BRCA -0.199; TCGA COAD -0.268; TCGA HNSC -0.11; TCGA KIRP -0.1; TCGA LIHC -0.154; TCGA PRAD -0.22; TCGA SARC -0.088; TCGA STAD -0.19; TCGA UCEC -0.294 |
hsa-miR-183-5p | DNALI1 | 9 cancers: BLCA; COAD; ESCA; KIRC; LGG; LIHC; LUSC; SARC; STAD | MirTarget | TCGA BLCA -0.201; TCGA COAD -0.289; TCGA ESCA -0.46; TCGA KIRC -0.072; TCGA LGG -0.133; TCGA LIHC -0.222; TCGA LUSC -0.66; TCGA SARC -0.138; TCGA STAD -0.161 |
hsa-miR-183-5p | SACS | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.371; TCGA BRCA -0.256; TCGA CESC -0.083; TCGA COAD -0.134; TCGA HNSC -0.073; TCGA KIRC -0.116; TCGA PAAD -0.286; TCGA PRAD -0.23; TCGA STAD -0.191; TCGA UCEC -0.142 |
hsa-miR-183-5p | CX3CL1 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.374; TCGA BRCA -0.484; TCGA CESC -0.242; TCGA COAD -0.17; TCGA HNSC -0.131; TCGA KIRC -0.227; TCGA LIHC -0.056; TCGA LUAD -0.286; TCGA LUSC -0.146; TCGA OV -0.14; TCGA PRAD -0.419; TCGA SARC -0.199; TCGA STAD -0.2 |
hsa-miR-183-5p | ABCA1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.151; TCGA BRCA -0.226; TCGA CESC -0.152; TCGA COAD -0.188; TCGA HNSC -0.154; TCGA KIRC -0.106; TCGA LIHC -0.064; TCGA LUAD -0.203; TCGA LUSC -0.144; TCGA OV -0.099; TCGA PAAD -0.176; TCGA STAD -0.169 |
hsa-miR-183-5p | ZEB1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.472; TCGA BRCA -0.26; TCGA CESC -0.251; TCGA COAD -0.43; TCGA ESCA -0.368; TCGA HNSC -0.259; TCGA KIRC -0.203; TCGA KIRP -0.129; TCGA LIHC -0.071; TCGA LUAD -0.325; TCGA LUSC -0.371; TCGA OV -0.197; TCGA PAAD -0.304; TCGA PRAD -0.398; TCGA SARC -0.063; TCGA STAD -0.525; TCGA UCEC -0.465 |
hsa-miR-183-5p | NCAM2 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.607; TCGA CESC -0.496; TCGA COAD -0.718; TCGA ESCA -0.297; TCGA HNSC -0.311; TCGA LUAD -0.333; TCGA LUSC -0.543; TCGA PAAD -0.44; TCGA PRAD -0.217; TCGA THCA -0.33; TCGA STAD -0.599; TCGA UCEC -0.293 |
hsa-miR-183-5p | MBNL1 | 13 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.186; TCGA BRCA -0.193; TCGA CESC -0.084; TCGA HNSC -0.087; TCGA LUAD -0.139; TCGA LUSC -0.106; TCGA OV -0.051; TCGA PAAD -0.178; TCGA PRAD -0.162; TCGA SARC -0.166; TCGA THCA -0.056; TCGA STAD -0.21; TCGA UCEC -0.167 |
hsa-miR-183-5p | MTMR6 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.083; TCGA BRCA -0.055; TCGA CESC -0.064; TCGA ESCA -0.095; TCGA HNSC -0.081; TCGA KIRP -0.055; TCGA LUAD -0.105; TCGA LUSC -0.22; TCGA OV -0.07; TCGA PRAD -0.055; TCGA STAD -0.051; TCGA UCEC -0.127 |
hsa-miR-183-5p | HLA-DMB | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; SARC | MirTarget | TCGA BLCA -0.375; TCGA BRCA -0.084; TCGA CESC -0.244; TCGA COAD -0.269; TCGA ESCA -0.401; TCGA HNSC -0.369; TCGA LGG -0.097; TCGA LUAD -0.289; TCGA LUSC -0.626; TCGA OV -0.166; TCGA PAAD -0.429; TCGA SARC -0.194 |
hsa-miR-183-5p | DTNA | 9 cancers: BLCA; COAD; ESCA; HNSC; LGG; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.664; TCGA COAD -0.389; TCGA ESCA -0.366; TCGA HNSC -0.296; TCGA LGG -0.059; TCGA PRAD -0.453; TCGA SARC -0.107; TCGA STAD -0.701; TCGA UCEC -0.379 |
hsa-miR-183-5p | FCHSD2 | 10 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.082; TCGA COAD -0.107; TCGA ESCA -0.11; TCGA KIRC -0.069; TCGA KIRP -0.074; TCGA LUSC -0.173; TCGA PAAD -0.164; TCGA PRAD -0.247; TCGA STAD -0.116; TCGA UCEC -0.059 |
hsa-miR-183-5p | TRPC6 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.105; TCGA BRCA -0.299; TCGA CESC -0.138; TCGA COAD -0.215; TCGA ESCA -0.248; TCGA KIRC -0.181; TCGA KIRP -0.479; TCGA LUAD -0.214; TCGA LUSC -0.421; TCGA PAAD -0.244; TCGA PRAD -0.558; TCGA STAD -0.119; TCGA UCEC -0.241 |
hsa-miR-183-5p | LCK | 12 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.231; TCGA CESC -0.218; TCGA ESCA -0.193; TCGA HNSC -0.189; TCGA LGG -0.105; TCGA LUAD -0.197; TCGA LUSC -0.356; TCGA OV -0.156; TCGA PAAD -0.219; TCGA PRAD -0.101; TCGA SARC -0.192; TCGA THCA -0.425 |
hsa-miR-183-5p | MICA | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; PRAD; THCA | MirTarget | TCGA BLCA -0.112; TCGA BRCA -0.101; TCGA CESC -0.08; TCGA ESCA -0.076; TCGA KIRC -0.105; TCGA LGG -0.111; TCGA LUAD -0.099; TCGA LUSC -0.07; TCGA PRAD -0.117; TCGA THCA -0.057 |
hsa-miR-183-5p | PRKACB | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.132; TCGA CESC -0.126; TCGA ESCA -0.181; TCGA HNSC -0.193; TCGA KIRP -0.056; TCGA LIHC -0.079; TCGA LUAD -0.102; TCGA LUSC -0.125; TCGA OV -0.06; TCGA PRAD -0.067; TCGA SARC -0.066; TCGA STAD -0.292; TCGA UCEC -0.186 |
hsa-miR-183-5p | TUB | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.325; TCGA BRCA -0.289; TCGA CESC -0.259; TCGA COAD -0.57; TCGA KIRC -0.137; TCGA KIRP -0.329; TCGA LUAD -0.259; TCGA PAAD -0.269; TCGA PRAD -0.126; TCGA STAD -0.586; TCGA UCEC -0.41 |
hsa-miR-183-5p | MEF2C | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.367; TCGA BRCA -0.305; TCGA CESC -0.252; TCGA COAD -0.248; TCGA ESCA -0.379; TCGA HNSC -0.517; TCGA KIRC -0.209; TCGA KIRP -0.166; TCGA LGG -0.067; TCGA LUAD -0.205; TCGA LUSC -0.534; TCGA OV -0.17; TCGA PAAD -0.333; TCGA PRAD -0.365; TCGA SARC -0.106; TCGA STAD -0.37; TCGA UCEC -0.392 |
hsa-miR-183-5p | CYYR1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.187; TCGA BRCA -0.381; TCGA CESC -0.224; TCGA COAD -0.282; TCGA ESCA -0.241; TCGA HNSC -0.162; TCGA KIRC -0.207; TCGA KIRP -0.235; TCGA LIHC -0.058; TCGA LUAD -0.383; TCGA LUSC -0.471; TCGA PAAD -0.262; TCGA PRAD -0.266; TCGA SARC -0.105; TCGA STAD -0.281; TCGA UCEC -0.312 |
hsa-miR-183-5p | LHFPL2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.14; TCGA BRCA -0.137; TCGA CESC -0.108; TCGA COAD -0.125; TCGA ESCA -0.156; TCGA HNSC -0.143; TCGA LGG -0.057; TCGA LUAD -0.169; TCGA LUSC -0.319; TCGA OV -0.063; TCGA PAAD -0.242; TCGA PRAD -0.278; TCGA STAD -0.124; TCGA UCEC -0.14 |
hsa-miR-183-5p | RABGAP1L | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.105; TCGA BRCA -0.053; TCGA CESC -0.081; TCGA ESCA -0.083; TCGA KIRP -0.155; TCGA LUAD -0.057; TCGA LUSC -0.059; TCGA PRAD -0.24; TCGA SARC -0.099; TCGA THCA -0.08; TCGA UCEC -0.091 |
hsa-miR-183-5p | GPCPD1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.12; TCGA BRCA -0.126; TCGA ESCA -0.164; TCGA HNSC -0.131; TCGA KIRC -0.059; TCGA LUSC -0.193; TCGA PAAD -0.073; TCGA PRAD -0.078; TCGA STAD -0.099 |
hsa-miR-183-5p | ABCA8 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.449; TCGA BRCA -0.952; TCGA CESC -0.323; TCGA COAD -1.073; TCGA ESCA -1.086; TCGA HNSC -0.563; TCGA LGG -0.098; TCGA LIHC -0.394; TCGA LUAD -0.761; TCGA LUSC -1.076; TCGA OV -0.219; TCGA PAAD -0.601; TCGA PRAD -0.367; TCGA SARC -0.207; TCGA THCA -0.181; TCGA STAD -0.868; TCGA UCEC -0.611 |
hsa-miR-183-5p | MAPK4 | 10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.265; TCGA BRCA -0.516; TCGA COAD -0.473; TCGA ESCA -0.352; TCGA LGG -0.084; TCGA LUAD -0.666; TCGA LUSC -0.564; TCGA PRAD -0.256; TCGA STAD -1.127; TCGA UCEC -0.183 |
hsa-miR-183-5p | AJAP1 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.106; TCGA BRCA -0.216; TCGA CESC -0.244; TCGA HNSC -0.216; TCGA KIRC -0.135; TCGA LGG -0.073; TCGA LUAD -0.405; TCGA LUSC -0.474; TCGA PRAD -0.397; TCGA THCA -0.362; TCGA STAD -0.176; TCGA UCEC -0.399 |
hsa-miR-183-5p | FOXP1 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.097; TCGA BRCA -0.052; TCGA CESC -0.079; TCGA ESCA -0.24; TCGA HNSC -0.184; TCGA LUAD -0.178; TCGA LUSC -0.341; TCGA OV -0.058; TCGA STAD -0.152; TCGA UCEC -0.147 |
hsa-miR-183-5p | CCL18 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA | MirTarget | TCGA BLCA -0.442; TCGA BRCA -0.143; TCGA COAD -0.452; TCGA ESCA -0.274; TCGA HNSC -0.288; TCGA LUAD -0.434; TCGA LUSC -0.524; TCGA PAAD -0.533; TCGA THCA -0.747 |
hsa-miR-183-5p | TPM1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.462; TCGA BRCA -0.09; TCGA COAD -0.141; TCGA ESCA -0.293; TCGA HNSC -0.172; TCGA KIRC -0.096; TCGA LUSC -0.157; TCGA OV -0.097; TCGA PAAD -0.22; TCGA PRAD -0.462; TCGA SARC -0.178; TCGA STAD -0.502; TCGA UCEC -0.259 |
hsa-miR-183-5p | NRIP2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.1; TCGA BRCA -0.269; TCGA CESC -0.171; TCGA COAD -0.168; TCGA ESCA -0.258; TCGA HNSC -0.156; TCGA KIRC -0.191; TCGA KIRP -0.272; TCGA LUAD -0.157; TCGA LUSC -0.139; TCGA OV -0.061; TCGA PRAD -0.173; TCGA STAD -0.26; TCGA UCEC -0.229 |
hsa-miR-183-5p | FRMD6 | 13 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.165; TCGA BRCA -0.168; TCGA CESC -0.198; TCGA COAD -0.403; TCGA KIRC -0.105; TCGA LUAD -0.119; TCGA OV -0.087; TCGA PAAD -0.385; TCGA PRAD -0.543; TCGA SARC -0.129; TCGA THCA -0.169; TCGA STAD -0.362; TCGA UCEC -0.351 |
hsa-miR-183-5p | RELL1 | 9 cancers: BLCA; ESCA; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.125; TCGA ESCA -0.128; TCGA KIRC -0.075; TCGA LUAD -0.182; TCGA LUSC -0.086; TCGA PRAD -0.074; TCGA SARC -0.141; TCGA STAD -0.065; TCGA UCEC -0.059 |
hsa-miR-183-5p | ZEB2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.497; TCGA BRCA -0.341; TCGA CESC -0.253; TCGA COAD -0.385; TCGA ESCA -0.328; TCGA HNSC -0.295; TCGA KIRC -0.093; TCGA KIRP -0.203; TCGA LUAD -0.367; TCGA LUSC -0.571; TCGA OV -0.149; TCGA PAAD -0.351; TCGA PRAD -0.419; TCGA SARC -0.172; TCGA THCA -0.134; TCGA STAD -0.309; TCGA UCEC -0.364 |
hsa-miR-183-5p | ATP2B4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.262; TCGA BRCA -0.181; TCGA CESC -0.099; TCGA COAD -0.297; TCGA ESCA -0.115; TCGA KIRC -0.08; TCGA LUAD -0.185; TCGA LUSC -0.18; TCGA PRAD -0.594; TCGA SARC -0.109; TCGA THCA -0.116; TCGA STAD -0.504; TCGA UCEC -0.135 |
hsa-miR-183-5p | MIER1 | 10 cancers: BLCA; CESC; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.062; TCGA CESC -0.064; TCGA ESCA -0.086; TCGA HNSC -0.094; TCGA LUSC -0.156; TCGA PAAD -0.068; TCGA PRAD -0.099; TCGA SARC -0.064; TCGA STAD -0.063; TCGA UCEC -0.106 |
hsa-miR-183-5p | PHLDB2 | 10 cancers: BLCA; BRCA; COAD; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.296; TCGA BRCA -0.244; TCGA COAD -0.34; TCGA LUAD -0.279; TCGA PAAD -0.182; TCGA PRAD -0.153; TCGA SARC -0.238; TCGA THCA -0.214; TCGA STAD -0.464; TCGA UCEC -0.346 |
hsa-miR-183-5p | KLRD1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.425; TCGA BRCA -0.194; TCGA CESC -0.417; TCGA COAD -0.478; TCGA ESCA -0.315; TCGA HNSC -0.439; TCGA KIRC -0.23; TCGA LIHC -0.125; TCGA LUAD -0.383; TCGA LUSC -0.524; TCGA OV -0.191; TCGA PAAD -0.512; TCGA PRAD -0.371; TCGA SARC -0.215; TCGA THCA -0.422; TCGA UCEC -0.164 |
hsa-miR-183-5p | VASH1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; UCEC | mirMAP | TCGA BLCA -0.199; TCGA BRCA -0.112; TCGA CESC -0.162; TCGA COAD -0.315; TCGA ESCA -0.175; TCGA HNSC -0.188; TCGA KIRC -0.228; TCGA LUAD -0.23; TCGA LUSC -0.362; TCGA OV -0.116; TCGA PAAD -0.156; TCGA UCEC -0.146 |
hsa-miR-183-5p | PPP1R12B | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.46; TCGA BRCA -0.359; TCGA CESC -0.293; TCGA COAD -0.435; TCGA ESCA -0.464; TCGA HNSC -0.351; TCGA KIRP -0.195; TCGA LUAD -0.201; TCGA LUSC -0.363; TCGA OV -0.105; TCGA PAAD -0.239; TCGA PRAD -0.543; TCGA SARC -0.368; TCGA STAD -0.724; TCGA UCEC -0.519 |
hsa-miR-183-5p | PITPNM2 | 12 cancers: BLCA; BRCA; COAD; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.189; TCGA BRCA -0.144; TCGA COAD -0.071; TCGA KIRP -0.075; TCGA LIHC -0.055; TCGA LUAD -0.107; TCGA LUSC -0.126; TCGA PRAD -0.263; TCGA SARC -0.099; TCGA THCA -0.05; TCGA STAD -0.218; TCGA UCEC -0.115 |
hsa-miR-183-5p | STX1B | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.33; TCGA BRCA -0.235; TCGA CESC -0.342; TCGA COAD -0.307; TCGA HNSC -0.137; TCGA KIRC -0.253; TCGA LIHC -0.152; TCGA LUAD -0.16; TCGA LUSC -0.099; TCGA PAAD -0.206; TCGA PRAD -0.173; TCGA THCA -0.179; TCGA STAD -0.273; TCGA UCEC -0.312 |
hsa-miR-183-5p | PPM1F | 13 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.123; TCGA BRCA -0.262; TCGA CESC -0.126; TCGA COAD -0.163; TCGA KIRC -0.217; TCGA KIRP -0.124; TCGA LUAD -0.201; TCGA LUSC -0.087; TCGA OV -0.132; TCGA PAAD -0.15; TCGA PRAD -0.113; TCGA STAD -0.138; TCGA UCEC -0.203 |
hsa-miR-183-5p | IGDCC4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.296; TCGA BRCA -0.229; TCGA CESC -0.193; TCGA COAD -0.197; TCGA ESCA -0.301; TCGA HNSC -0.307; TCGA LUAD -0.113; TCGA OV -0.12; TCGA PAAD -0.521; TCGA PRAD -0.45; TCGA STAD -0.15; TCGA UCEC -0.294 |
hsa-miR-183-5p | NOVA2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; OV; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.084; TCGA BRCA -0.2; TCGA CESC -0.115; TCGA COAD -0.252; TCGA ESCA -0.207; TCGA KIRC -0.354; TCGA KIRP -0.218; TCGA LUAD -0.356; TCGA LUSC -0.481; TCGA OV -0.153; TCGA PRAD -0.099; TCGA STAD -0.117; TCGA UCEC -0.171 |
hsa-miR-183-5p | TSPAN11 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.336; TCGA BRCA -0.378; TCGA COAD -0.361; TCGA ESCA -0.357; TCGA LUSC -0.378; TCGA PAAD -0.458; TCGA PRAD -0.457; TCGA THCA -0.239; TCGA STAD -0.336 |
hsa-miR-183-5p | PHACTR1 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.22; TCGA BRCA -0.135; TCGA ESCA -0.16; TCGA HNSC -0.178; TCGA KIRP -0.386; TCGA LUAD -0.377; TCGA LUSC -0.513; TCGA PAAD -0.147; TCGA PRAD -0.111; TCGA THCA -0.235; TCGA STAD -0.306 |
hsa-miR-183-5p | RIMS3 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.172; TCGA BRCA -0.243; TCGA CESC -0.248; TCGA HNSC -0.163; TCGA KIRP -0.107; TCGA LUSC -0.372; TCGA PRAD -0.436; TCGA THCA -0.144; TCGA STAD -0.399; TCGA UCEC -0.294 |
hsa-miR-183-5p | THRA | 9 cancers: BLCA; BRCA; ESCA; KIRC; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.224; TCGA BRCA -0.181; TCGA ESCA -0.168; TCGA KIRC -0.104; TCGA LUAD -0.096; TCGA LUSC -0.151; TCGA PRAD -0.16; TCGA STAD -0.06; TCGA UCEC -0.221 |
hsa-miR-183-5p | WDFY4 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.523; TCGA BRCA -0.087; TCGA CESC -0.332; TCGA COAD -0.4; TCGA ESCA -0.46; TCGA HNSC -0.388; TCGA KIRC -0.113; TCGA LGG -0.091; TCGA LUAD -0.236; TCGA LUSC -0.713; TCGA OV -0.204; TCGA PAAD -0.592; TCGA PRAD -0.206; TCGA SARC -0.182; TCGA THCA -0.569; TCGA STAD -0.153 |
hsa-miR-183-5p | KIAA1614 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.373; TCGA BRCA -0.4; TCGA COAD -0.37; TCGA HNSC -0.075; TCGA KIRC -0.151; TCGA KIRP -0.19; TCGA LUAD -0.238; TCGA LUSC -0.127; TCGA OV -0.091; TCGA PAAD -0.22; TCGA PRAD -0.571; TCGA SARC -0.086; TCGA STAD -0.373; TCGA UCEC -0.192 |
hsa-miR-183-5p | RHBDL3 | 10 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LIHC; OV; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.267; TCGA BRCA -0.258; TCGA CESC -0.213; TCGA KIRC -0.087; TCGA KIRP -0.421; TCGA LIHC -0.22; TCGA OV -0.192; TCGA PRAD -0.586; TCGA STAD -0.305; TCGA UCEC -0.161 |
hsa-miR-183-5p | NFIC | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.259; TCGA CESC -0.116; TCGA COAD -0.262; TCGA ESCA -0.082; TCGA HNSC -0.239; TCGA KIRP -0.143; TCGA LIHC -0.074; TCGA LUAD -0.077; TCGA LUSC -0.097; TCGA PRAD -0.157; TCGA SARC -0.104; TCGA STAD -0.272; TCGA UCEC -0.097 |
hsa-miR-183-5p | WTIP | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.114; TCGA BRCA -0.233; TCGA COAD -0.314; TCGA ESCA -0.104; TCGA HNSC -0.116; TCGA KIRP -0.109; TCGA LUAD -0.254; TCGA LUSC -0.26; TCGA PAAD -0.285; TCGA PRAD -0.065; TCGA THCA -0.239; TCGA STAD -0.249; TCGA UCEC -0.123 |
hsa-miR-183-5p | DST | 10 cancers: BLCA; BRCA; HNSC; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.168; TCGA BRCA -0.432; TCGA HNSC -0.084; TCGA LUAD -0.349; TCGA OV -0.093; TCGA PRAD -0.361; TCGA SARC -0.161; TCGA THCA -0.206; TCGA STAD -0.312; TCGA UCEC -0.206 |
hsa-miR-183-5p | MECP2 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRP; OV; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.071; TCGA BRCA -0.057; TCGA COAD -0.065; TCGA ESCA -0.068; TCGA KIRP -0.077; TCGA OV -0.081; TCGA PRAD -0.103; TCGA STAD -0.143; TCGA UCEC -0.12 |
hsa-miR-183-5p | CIITA | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.323; TCGA BRCA -0.13; TCGA CESC -0.42; TCGA COAD -0.407; TCGA ESCA -0.445; TCGA HNSC -0.437; TCGA KIRC -0.089; TCGA KIRP -0.116; TCGA LGG -0.138; TCGA LUAD -0.352; TCGA LUSC -0.648; TCGA OV -0.162; TCGA PAAD -0.474; TCGA PRAD -0.219; TCGA SARC -0.211; TCGA THCA -0.497 |
hsa-miR-183-5p | ZNF154 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.284; TCGA BRCA -0.261; TCGA CESC -0.182; TCGA COAD -0.306; TCGA ESCA -0.379; TCGA HNSC -0.208; TCGA KIRC -0.157; TCGA KIRP -0.322; TCGA LUAD -0.131; TCGA LUSC -0.333; TCGA OV -0.13; TCGA PAAD -0.252; TCGA PRAD -0.57; TCGA THCA -0.071; TCGA STAD -0.357; TCGA UCEC -0.187 |
hsa-miR-183-5p | CBX6 | 9 cancers: BLCA; BRCA; COAD; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.171; TCGA BRCA -0.179; TCGA COAD -0.244; TCGA OV -0.092; TCGA PAAD -0.122; TCGA PRAD -0.278; TCGA THCA -0.063; TCGA STAD -0.385; TCGA UCEC -0.253 |
hsa-miR-183-5p | SPN | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.37; TCGA BRCA -0.111; TCGA CESC -0.358; TCGA COAD -0.256; TCGA ESCA -0.299; TCGA HNSC -0.385; TCGA KIRC -0.201; TCGA LGG -0.089; TCGA LUAD -0.522; TCGA LUSC -0.787; TCGA OV -0.261; TCGA PAAD -0.368; TCGA PRAD -0.169; TCGA SARC -0.157; TCGA THCA -0.484 |
hsa-miR-183-5p | C14orf132 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.259; TCGA BRCA -0.204; TCGA CESC -0.223; TCGA COAD -0.583; TCGA ESCA -0.169; TCGA HNSC -0.171; TCGA KIRP -0.232; TCGA LUAD -0.325; TCGA LUSC -0.545; TCGA PRAD -0.294; TCGA STAD -0.649; TCGA UCEC -0.351 |
hsa-miR-183-5p | BNC2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.677; TCGA BRCA -0.247; TCGA CESC -0.276; TCGA COAD -0.674; TCGA ESCA -0.384; TCGA HNSC -0.363; TCGA LGG -0.06; TCGA LUAD -0.299; TCGA LUSC -0.478; TCGA PAAD -0.599; TCGA PRAD -0.546; TCGA THCA -0.512; TCGA STAD -0.613; TCGA UCEC -0.639 |
hsa-miR-183-5p | NPAS3 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUSC; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.212; TCGA BRCA -0.323; TCGA COAD -0.489; TCGA ESCA -0.338; TCGA HNSC -0.353; TCGA KIRP -0.11; TCGA LUSC -0.245; TCGA PRAD -0.197; TCGA THCA -0.154; TCGA STAD -0.593 |
hsa-miR-183-5p | TCF4 | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.28; TCGA BRCA -0.243; TCGA COAD -0.346; TCGA KIRC -0.225; TCGA KIRP -0.185; TCGA LUAD -0.253; TCGA LUSC -0.068; TCGA PAAD -0.308; TCGA PRAD -0.249; TCGA STAD -0.247; TCGA UCEC -0.202 |
hsa-miR-183-5p | NR3C1 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.335; TCGA BRCA -0.358; TCGA CESC -0.136; TCGA COAD -0.313; TCGA HNSC -0.083; TCGA KIRC -0.082; TCGA KIRP -0.108; TCGA LIHC -0.079; TCGA LUAD -0.131; TCGA LUSC -0.206; TCGA OV -0.125; TCGA PAAD -0.15; TCGA PRAD -0.292; TCGA STAD -0.318; TCGA UCEC -0.394 |
hsa-miR-183-5p | CELF2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.553; TCGA BRCA -0.423; TCGA CESC -0.311; TCGA ESCA -0.451; TCGA HNSC -0.367; TCGA LUAD -0.339; TCGA LUSC -0.632; TCGA OV -0.174; TCGA PAAD -0.427; TCGA PRAD -0.484; TCGA SARC -0.094; TCGA THCA -0.143; TCGA STAD -0.5; TCGA UCEC -0.292 |
hsa-miR-183-5p | CACNB4 | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.336; TCGA BRCA -0.24; TCGA ESCA -0.265; TCGA HNSC -0.179; TCGA KIRP -0.266; TCGA LUAD -0.255; TCGA LUSC -0.144; TCGA PAAD -0.253; TCGA PRAD -0.362; TCGA SARC -0.109; TCGA STAD -0.343; TCGA UCEC -0.18 |
hsa-miR-183-5p | PDE4D | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.288; TCGA BRCA -0.075; TCGA COAD -0.102; TCGA ESCA -0.215; TCGA HNSC -0.217; TCGA LUAD -0.276; TCGA LUSC -0.236; TCGA OV -0.208; TCGA PRAD -0.303; TCGA SARC -0.136; TCGA STAD -0.284; TCGA UCEC -0.279 |
hsa-miR-183-5p | PRKCA | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.168; TCGA BRCA -0.382; TCGA CESC -0.196; TCGA ESCA -0.311; TCGA HNSC -0.124; TCGA LUAD -0.191; TCGA LUSC -0.24; TCGA OV -0.182; TCGA PAAD -0.122; TCGA PRAD -0.392; TCGA STAD -0.164; TCGA UCEC -0.286 |
hsa-miR-183-5p | FAT3 | 11 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.325; TCGA BRCA -0.368; TCGA COAD -0.513; TCGA ESCA -0.226; TCGA LUAD -0.404; TCGA LUSC -0.524; TCGA OV -0.31; TCGA PAAD -0.376; TCGA PRAD -0.889; TCGA STAD -0.903; TCGA UCEC -0.413 |
hsa-miR-183-5p | CPEB2 | 15 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.187; TCGA CESC -0.111; TCGA ESCA -0.093; TCGA HNSC -0.117; TCGA KIRC -0.051; TCGA KIRP -0.093; TCGA LGG -0.055; TCGA LIHC -0.052; TCGA LUAD -0.145; TCGA LUSC -0.206; TCGA OV -0.078; TCGA PRAD -0.056; TCGA SARC -0.093; TCGA STAD -0.158; TCGA UCEC -0.184 |
hsa-miR-183-5p | PLCXD3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.222; TCGA BRCA -0.7; TCGA CESC -0.318; TCGA COAD -0.668; TCGA ESCA -0.894; TCGA KIRP -0.386; TCGA LUAD -0.666; TCGA LUSC -0.733; TCGA PRAD -0.246; TCGA SARC -0.158; TCGA THCA -0.213; TCGA STAD -0.836; TCGA UCEC -0.614 |
hsa-miR-183-5p | HBEGF | 10 cancers: BLCA; BRCA; KIRP; LGG; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.237; TCGA BRCA -0.257; TCGA KIRP -0.185; TCGA LGG -0.053; TCGA LUAD -0.425; TCGA LUSC -0.334; TCGA OV -0.108; TCGA PRAD -0.244; TCGA THCA -0.122; TCGA UCEC -0.17 |
hsa-miR-183-5p | SIDT2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; STAD; UCEC | miRNATAP | TCGA BLCA -0.143; TCGA BRCA -0.155; TCGA CESC -0.089; TCGA COAD -0.097; TCGA ESCA -0.181; TCGA HNSC -0.069; TCGA KIRP -0.051; TCGA LIHC -0.062; TCGA LUAD -0.2; TCGA LUSC -0.241; TCGA STAD -0.076; TCGA UCEC -0.083 |
hsa-miR-183-5p | SPRED1 | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; UCEC | miRNATAP | TCGA BLCA -0.198; TCGA BRCA -0.176; TCGA HNSC -0.055; TCGA KIRC -0.122; TCGA KIRP -0.073; TCGA LUAD -0.124; TCGA LUSC -0.177; TCGA OV -0.113; TCGA PAAD -0.091; TCGA PRAD -0.245; TCGA UCEC -0.153 |
hsa-miR-183-5p | MRVI1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.485; TCGA BRCA -0.28; TCGA CESC -0.287; TCGA COAD -0.464; TCGA ESCA -0.467; TCGA HNSC -0.171; TCGA KIRP -0.347; TCGA LUAD -0.288; TCGA LUSC -0.432; TCGA OV -0.145; TCGA PAAD -0.342; TCGA PRAD -0.596; TCGA SARC -0.427; TCGA STAD -0.64; TCGA UCEC -0.442 |
hsa-miR-183-5p | CPEB1 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.727; TCGA BRCA -0.429; TCGA COAD -0.743; TCGA ESCA -0.426; TCGA HNSC -0.327; TCGA KIRP -0.295; TCGA LGG -0.065; TCGA LUAD -0.464; TCGA LUSC -0.197; TCGA OV -0.259; TCGA PAAD -0.278; TCGA PRAD -0.701; TCGA SARC -0.14; TCGA STAD -0.78; TCGA UCEC -0.606 |
hsa-miR-183-5p | HECTD2 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.189; TCGA CESC -0.134; TCGA COAD -0.236; TCGA ESCA -0.212; TCGA HNSC -0.161; TCGA KIRC -0.072; TCGA KIRP -0.088; TCGA LUSC -0.117; TCGA PAAD -0.149; TCGA PRAD -0.309; TCGA THCA -0.08; TCGA STAD -0.311; TCGA UCEC -0.236 |
hsa-miR-183-5p | ZDHHC15 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.343; TCGA BRCA -0.303; TCGA CESC -0.248; TCGA COAD -0.553; TCGA ESCA -0.402; TCGA HNSC -0.378; TCGA KIRP -0.192; TCGA LUAD -0.246; TCGA LUSC -0.512; TCGA OV -0.143; TCGA PRAD -0.498; TCGA STAD -0.571; TCGA UCEC -0.379 |
hsa-miR-183-5p | SCN3A | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.318; TCGA BRCA -0.7; TCGA CESC -0.15; TCGA ESCA -0.448; TCGA HNSC -0.176; TCGA OV -0.204; TCGA PRAD -0.232; TCGA SARC -0.266; TCGA THCA -0.353; TCGA STAD -0.337; TCGA UCEC -0.203 |
hsa-miR-183-5p | RORA | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.241; TCGA BRCA -0.202; TCGA CESC -0.173; TCGA COAD -0.273; TCGA ESCA -0.151; TCGA HNSC -0.198; TCGA KIRC -0.133; TCGA KIRP -0.123; TCGA LIHC -0.173; TCGA LUAD -0.248; TCGA LUSC -0.153; TCGA OV -0.12; TCGA PAAD -0.211; TCGA PRAD -0.148; TCGA STAD -0.299; TCGA UCEC -0.221 |
hsa-miR-183-5p | LMO3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.562; TCGA BRCA -0.332; TCGA CESC -0.224; TCGA COAD -0.85; TCGA ESCA -0.476; TCGA HNSC -0.209; TCGA KIRP -0.602; TCGA LUSC -0.878; TCGA PAAD -0.283; TCGA PRAD -0.586; TCGA STAD -0.833; TCGA UCEC -0.386 |
hsa-miR-183-5p | FAM46A | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUSC; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.189; TCGA BRCA -0.113; TCGA CESC -0.098; TCGA ESCA -0.219; TCGA HNSC -0.17; TCGA LIHC -0.077; TCGA LUSC -0.322; TCGA PRAD -0.179; TCGA SARC -0.115; TCGA THCA -0.139; TCGA UCEC -0.142 |
hsa-miR-183-5p | RUNX1T1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.508; TCGA BRCA -0.475; TCGA CESC -0.371; TCGA COAD -0.579; TCGA ESCA -0.46; TCGA HNSC -0.328; TCGA KIRC -0.181; TCGA KIRP -0.413; TCGA LUAD -0.261; TCGA LUSC -0.654; TCGA OV -0.233; TCGA PAAD -0.241; TCGA PRAD -0.554; TCGA STAD -0.564; TCGA UCEC -0.493 |
hsa-miR-183-5p | RHOBTB1 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; UCEC | miRNATAP | TCGA BLCA -0.071; TCGA COAD -0.116; TCGA ESCA -0.189; TCGA HNSC -0.121; TCGA KIRC -0.15; TCGA LIHC -0.096; TCGA LUAD -0.076; TCGA LUSC -0.201; TCGA PAAD -0.172; TCGA PRAD -0.156; TCGA UCEC -0.056 |
hsa-miR-183-5p | SPTBN1 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; UCEC | miRNATAP | TCGA BLCA -0.061; TCGA BRCA -0.285; TCGA ESCA -0.175; TCGA HNSC -0.065; TCGA KIRC -0.075; TCGA KIRP -0.09; TCGA LUAD -0.249; TCGA LUSC -0.259; TCGA PRAD -0.191; TCGA UCEC -0.139 |
hsa-miR-183-5p | PKNOX2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.292; TCGA BRCA -0.475; TCGA COAD -0.544; TCGA ESCA -0.358; TCGA HNSC -0.405; TCGA KIRP -0.491; TCGA LUAD -0.593; TCGA LUSC -0.708; TCGA OV -0.166; TCGA PAAD -0.359; TCGA PRAD -0.205; TCGA STAD -0.64; TCGA UCEC -0.401 |
hsa-miR-183-5p | KIF13A | 10 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.184; TCGA BRCA -0.14; TCGA KIRC -0.054; TCGA KIRP -0.068; TCGA LIHC -0.066; TCGA LUAD -0.143; TCGA PRAD -0.148; TCGA SARC -0.067; TCGA STAD -0.122; TCGA UCEC -0.14 |
hsa-miR-183-5p | PDE3A | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.342; TCGA BRCA -0.3; TCGA COAD -0.319; TCGA ESCA -0.563; TCGA KIRP -0.434; TCGA LUSC -0.398; TCGA PAAD -0.331; TCGA PRAD -0.417; TCGA SARC -0.209; TCGA STAD -0.544; TCGA UCEC -0.159 |
hsa-miR-183-5p | ZFPM2 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.591; TCGA BRCA -0.318; TCGA CESC -0.236; TCGA COAD -0.516; TCGA ESCA -0.357; TCGA HNSC -0.419; TCGA KIRC -0.178; TCGA KIRP -0.381; TCGA LIHC -0.094; TCGA LUAD -0.309; TCGA LUSC -0.524; TCGA OV -0.317; TCGA PAAD -0.444; TCGA PRAD -0.535; TCGA SARC -0.199; TCGA THCA -0.199; TCGA STAD -0.574; TCGA UCEC -0.711 |
hsa-miR-183-5p | SIK3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; STAD | miRNATAP | TCGA BLCA -0.129; TCGA BRCA -0.129; TCGA CESC -0.084; TCGA COAD -0.064; TCGA ESCA -0.109; TCGA HNSC -0.089; TCGA KIRP -0.102; TCGA LIHC -0.067; TCGA LUAD -0.072; TCGA LUSC -0.07; TCGA PRAD -0.148; TCGA STAD -0.157 |
hsa-miR-183-5p | SLITRK3 | 11 cancers: BLCA; COAD; ESCA; LIHC; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.488; TCGA COAD -0.856; TCGA ESCA -0.373; TCGA LIHC -0.241; TCGA LUAD -0.218; TCGA OV -0.271; TCGA PAAD -0.467; TCGA PRAD -0.827; TCGA SARC -0.194; TCGA STAD -1.02; TCGA UCEC -0.799 |
hsa-miR-183-5p | RAB11FIP2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.106; TCGA BRCA -0.143; TCGA CESC -0.055; TCGA ESCA -0.183; TCGA HNSC -0.087; TCGA LIHC -0.07; TCGA LUAD -0.112; TCGA LUSC -0.252; TCGA PAAD -0.098; TCGA PRAD -0.192; TCGA STAD -0.163; TCGA UCEC -0.209 |
hsa-miR-183-5p | PLXNA4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.628; TCGA BRCA -0.551; TCGA CESC -0.167; TCGA COAD -0.711; TCGA ESCA -0.349; TCGA KIRP -0.318; TCGA LUAD -0.241; TCGA LUSC -0.468; TCGA PAAD -0.57; TCGA PRAD -0.278; TCGA SARC -0.156; TCGA STAD -0.489 |
hsa-miR-183-5p | NFE2L1 | 11 cancers: BLCA; BRCA; CESC; HNSC; LGG; LIHC; LUAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.086; TCGA BRCA -0.068; TCGA CESC -0.069; TCGA HNSC -0.089; TCGA LGG -0.056; TCGA LIHC -0.074; TCGA LUAD -0.088; TCGA PRAD -0.128; TCGA SARC -0.063; TCGA STAD -0.064; TCGA UCEC -0.117 |
hsa-miR-183-5p | NRP2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.513; TCGA BRCA -0.16; TCGA CESC -0.129; TCGA COAD -0.409; TCGA ESCA -0.159; TCGA KIRC -0.191; TCGA LUAD -0.191; TCGA LUSC -0.221; TCGA OV -0.189; TCGA PAAD -0.274; TCGA PRAD -0.462; TCGA THCA -0.226; TCGA STAD -0.429; TCGA UCEC -0.224 |
hsa-miR-183-5p | THSD7B | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.4; TCGA BRCA -0.503; TCGA COAD -0.52; TCGA KIRC -0.194; TCGA KIRP -0.469; TCGA LUAD -0.218; TCGA PAAD -0.238; TCGA PRAD -0.497; TCGA STAD -0.664 |
hsa-miR-183-5p | GREM2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.485; TCGA BRCA -0.531; TCGA CESC -0.291; TCGA COAD -0.702; TCGA ESCA -0.555; TCGA HNSC -0.425; TCGA KIRP -0.33; TCGA LIHC -0.412; TCGA LUSC -0.681; TCGA PAAD -0.479; TCGA PRAD -0.132; TCGA THCA -0.312; TCGA STAD -0.846; TCGA UCEC -0.415 |
hsa-miR-183-5p | PRUNE2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.924; TCGA BRCA -0.355; TCGA CESC -0.282; TCGA COAD -0.229; TCGA ESCA -0.755; TCGA HNSC -0.667; TCGA KIRC -0.299; TCGA LGG -0.061; TCGA LUAD -0.158; TCGA LUSC -0.51; TCGA PRAD -0.356; TCGA SARC -0.379; TCGA THCA -0.198; TCGA STAD -0.939; TCGA UCEC -0.616 |
hsa-miR-183-5p | RHOB | 11 cancers: BLCA; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.222; TCGA ESCA -0.164; TCGA KIRC -0.275; TCGA LIHC -0.221; TCGA LUAD -0.129; TCGA LUSC -0.259; TCGA PAAD -0.121; TCGA PRAD -0.378; TCGA SARC -0.074; TCGA STAD -0.398; TCGA UCEC -0.175 |
hsa-miR-183-5p | KCNMA1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.675; TCGA BRCA -0.183; TCGA CESC -0.34; TCGA COAD -0.616; TCGA ESCA -0.502; TCGA HNSC -0.234; TCGA KIRC -0.323; TCGA LIHC -0.195; TCGA LUAD -0.194; TCGA LUSC -0.3; TCGA PAAD -0.171; TCGA PRAD -0.569; TCGA STAD -0.972; TCGA UCEC -0.502 |
hsa-miR-183-5p | MTUS1 | 12 cancers: BRCA; CESC; ESCA; KIRP; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.156; TCGA CESC -0.092; TCGA ESCA -0.153; TCGA KIRP -0.099; TCGA LGG -0.067; TCGA LIHC -0.06; TCGA LUSC -0.087; TCGA OV -0.071; TCGA PRAD -0.139; TCGA SARC -0.106; TCGA THCA -0.086; TCGA UCEC -0.094 |
hsa-miR-183-5p | PDE8A | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.097; TCGA ESCA -0.116; TCGA HNSC -0.089; TCGA KIRC -0.076; TCGA KIRP -0.052; TCGA LGG -0.076; TCGA LUAD -0.08; TCGA LUSC -0.08; TCGA PRAD -0.055; TCGA UCEC -0.083 |
hsa-miR-183-5p | AMIGO2 | 10 cancers: BRCA; KIRP; LGG; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.269; TCGA KIRP -0.315; TCGA LGG -0.221; TCGA LUSC -0.343; TCGA OV -0.191; TCGA PRAD -0.223; TCGA SARC -0.183; TCGA THCA -0.203; TCGA STAD -0.158; TCGA UCEC -0.288 |
hsa-miR-183-5p | KIAA0355 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.145; TCGA ESCA -0.132; TCGA HNSC -0.069; TCGA KIRC -0.117; TCGA KIRP -0.067; TCGA LUAD -0.053; TCGA LUSC -0.127; TCGA PAAD -0.066; TCGA STAD -0.085; TCGA UCEC -0.107 |
hsa-miR-183-5p | SNX1 | 12 cancers: BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.121; TCGA CESC -0.083; TCGA ESCA -0.07; TCGA HNSC -0.053; TCGA LUAD -0.141; TCGA LUSC -0.107; TCGA PAAD -0.104; TCGA PRAD -0.051; TCGA SARC -0.051; TCGA THCA -0.143; TCGA STAD -0.139; TCGA UCEC -0.094 |
hsa-miR-183-5p | VAT1 | 9 cancers: BRCA; COAD; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.058; TCGA COAD -0.116; TCGA KIRC -0.079; TCGA LUAD -0.08; TCGA LUSC -0.155; TCGA PRAD -0.079; TCGA SARC -0.124; TCGA STAD -0.073; TCGA UCEC -0.092 |
hsa-miR-183-5p | ZNF662 | 10 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.236; TCGA COAD -0.401; TCGA ESCA -0.284; TCGA HNSC -0.193; TCGA LUAD -0.231; TCGA LUSC -0.382; TCGA OV -0.114; TCGA PRAD -0.252; TCGA STAD -0.519; TCGA UCEC -0.307 |
hsa-miR-183-5p | CELF6 | 10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; THCA; UCEC | MirTarget | TCGA BRCA -0.167; TCGA CESC -0.184; TCGA ESCA -0.277; TCGA KIRC -0.153; TCGA KIRP -0.122; TCGA LIHC -0.089; TCGA LUAD -0.201; TCGA LUSC -0.118; TCGA THCA -0.187; TCGA UCEC -0.143 |
hsa-miR-183-5p | TRIM5 | 10 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BRCA -0.079; TCGA CESC -0.146; TCGA ESCA -0.087; TCGA HNSC -0.194; TCGA LGG -0.09; TCGA LUAD -0.098; TCGA LUSC -0.209; TCGA PAAD -0.178; TCGA PRAD -0.084; TCGA STAD -0.06 |
hsa-miR-183-5p | NTN4 | 12 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.341; TCGA CESC -0.169; TCGA ESCA -0.364; TCGA HNSC -0.303; TCGA LIHC -0.093; TCGA LUAD -0.409; TCGA LUSC -0.503; TCGA OV -0.186; TCGA PRAD -0.366; TCGA SARC -0.098; TCGA STAD -0.282; TCGA UCEC -0.236 |
hsa-miR-183-5p | TCF7L2 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.256; TCGA CESC -0.052; TCGA ESCA -0.139; TCGA HNSC -0.056; TCGA KIRC -0.074; TCGA KIRP -0.056; TCGA LUAD -0.13; TCGA LUSC -0.161; TCGA OV -0.072; TCGA PRAD -0.068; TCGA UCEC -0.123 |
hsa-miR-183-5p | SESN1 | 11 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.161; TCGA CESC -0.08; TCGA ESCA -0.182; TCGA HNSC -0.122; TCGA LIHC -0.066; TCGA LUAD -0.22; TCGA LUSC -0.242; TCGA PAAD -0.145; TCGA SARC -0.111; TCGA STAD -0.081; TCGA UCEC -0.135 |
hsa-miR-183-5p | CLCN6 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.201; TCGA CESC -0.086; TCGA COAD -0.115; TCGA ESCA -0.112; TCGA KIRC -0.142; TCGA KIRP -0.068; TCGA LUAD -0.089; TCGA LUSC -0.171; TCGA THCA -0.075; TCGA STAD -0.152; TCGA UCEC -0.151 |
hsa-miR-183-5p | KCND1 | 9 cancers: BRCA; CESC; COAD; ESCA; LGG; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.125; TCGA CESC -0.111; TCGA COAD -0.21; TCGA ESCA -0.125; TCGA LGG -0.068; TCGA PRAD -0.24; TCGA THCA -0.123; TCGA STAD -0.29; TCGA UCEC -0.138 |
hsa-miR-183-5p | YPEL2 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.059; TCGA CESC -0.146; TCGA COAD -0.08; TCGA ESCA -0.296; TCGA HNSC -0.14; TCGA KIRC -0.074; TCGA LUAD -0.061; TCGA LUSC -0.239; TCGA SARC -0.094; TCGA THCA -0.086; TCGA STAD -0.131; TCGA UCEC -0.183 |
hsa-miR-183-5p | RBMS1 | 11 cancers: BRCA; CESC; COAD; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.19; TCGA CESC -0.076; TCGA COAD -0.248; TCGA LGG -0.062; TCGA LIHC -0.05; TCGA LUAD -0.103; TCGA LUSC -0.085; TCGA PAAD -0.254; TCGA PRAD -0.274; TCGA STAD -0.254; TCGA UCEC -0.194 |
hsa-miR-183-5p | FCHO2 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.084; TCGA CESC -0.104; TCGA ESCA -0.145; TCGA HNSC -0.187; TCGA KIRP -0.063; TCGA LUAD -0.168; TCGA LUSC -0.327; TCGA PRAD -0.058; TCGA STAD -0.055; TCGA UCEC -0.133 |
hsa-miR-183-5p | MORC3 | 10 cancers: BRCA; CESC; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.063; TCGA CESC -0.1; TCGA HNSC -0.112; TCGA LIHC -0.062; TCGA LUAD -0.065; TCGA LUSC -0.065; TCGA PRAD -0.102; TCGA THCA -0.105; TCGA STAD -0.07; TCGA UCEC -0.17 |
hsa-miR-183-5p | PIM1 | 11 cancers: BRCA; CESC; COAD; HNSC; LIHC; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.185; TCGA CESC -0.136; TCGA COAD -0.186; TCGA HNSC -0.169; TCGA LIHC -0.141; TCGA LUSC -0.156; TCGA OV -0.107; TCGA PAAD -0.122; TCGA THCA -0.126; TCGA STAD -0.13; TCGA UCEC -0.129 |
hsa-miR-183-5p | KLHL3 | 10 cancers: BRCA; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.283; TCGA COAD -0.197; TCGA HNSC -0.089; TCGA KIRP -0.161; TCGA LGG -0.084; TCGA LUAD -0.215; TCGA LUSC -0.094; TCGA PRAD -0.229; TCGA STAD -0.242; TCGA UCEC -0.121 |
hsa-miR-183-5p | BCL6 | 11 cancers: BRCA; CESC; COAD; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.277; TCGA CESC -0.089; TCGA COAD -0.221; TCGA LIHC -0.104; TCGA LUAD -0.066; TCGA PAAD -0.251; TCGA PRAD -0.162; TCGA SARC -0.093; TCGA THCA -0.223; TCGA STAD -0.249; TCGA UCEC -0.08 |
hsa-miR-183-5p | NIPAL4 | 9 cancers: CESC; COAD; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA CESC -0.39; TCGA COAD -0.332; TCGA HNSC -0.24; TCGA LUAD -0.158; TCGA PAAD -0.29; TCGA PRAD -0.686; TCGA SARC -0.3; TCGA THCA -0.295; TCGA STAD -0.901 |
hsa-miR-183-5p | KIF21B | 10 cancers: CESC; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; THCA; UCEC | mirMAP | TCGA CESC -0.193; TCGA ESCA -0.222; TCGA HNSC -0.232; TCGA KIRC -0.2; TCGA LUAD -0.081; TCGA LUSC -0.415; TCGA OV -0.104; TCGA PAAD -0.229; TCGA THCA -0.359; TCGA UCEC -0.063 |
hsa-miR-183-5p | TIAM1 | 9 cancers: CESC; COAD; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA CESC -0.154; TCGA COAD -0.224; TCGA KIRP -0.082; TCGA LUAD -0.238; TCGA LUSC -0.083; TCGA PRAD -0.187; TCGA THCA -0.135; TCGA STAD -0.181; TCGA UCEC -0.226 |
hsa-miR-183-5p | EMP2 | 10 cancers: KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA KIRC -0.123; TCGA KIRP -0.133; TCGA LGG -0.07; TCGA LIHC -0.105; TCGA LUAD -0.387; TCGA LUSC -0.417; TCGA PRAD -0.12; TCGA SARC -0.077; TCGA THCA -0.137; TCGA STAD -0.082 |
Enriched cancer pathways of putative targets